Article
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer.
Breast cancer research : BCR - 25 Jul 2020
Lips Esther H, Benard-Slagter Anne, Opdam Mark, Scheerman Caroline E, Wesseling Jelle, Hogervorst Frans B L, Linn Sabine C, Savola Suvi, Nederlof Petra M
Abstract excerpt
BACKGROUND: We previously showed that BRCA-like profiles can be used to preselect individuals with the highest risk of carrying BRCA mutations but could also indicate which patients would benefit from double-strand break inducing chemotherapy. A simple, robust, and reliable assay for clinical use that utilizes limited amounts of formalin-fixed, paraffin-embedded tumor tissue to assess BRCAness status in both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
